Market Access News | pharmaphorum

News

Japan first approval for GSK’s bepirovirsen for CHB

Japan has approved GSK's antisense oligonucleoide Hibsago (bepirovirsen) as a functional cure in chronic hepatitis B virus infection in adult patients

News

UK MHRA authorises orforglipron private prescription

Eli Lilly has announced that orforglipron (Foundayo) is now available to be prescribed for eligible adults via private prescription.

News

J&J scores EU approval for Tecvayli combo in second line

Johnson & Johnson's multiple myeloma regimen is now approved as a second line treatment in both the US and the EU.

News

Trump taps White House aide Heidi Overton to lead FDA

US President Donald Trump has nominated White House health policy aide Heidi Overton to take up the mantle of FDA commissioner.

News

Inside of intestine at bacterial level - concept of microbiome meds

MHRA clarifies UK position on microbiome-based medicines

The MHRA has published its position paper clarifying how microbiome-based medicines can be made available for patients in the UK.

News

Pfizer, Valneva Lyme vaccine starts review in Europe

After reporting mixed clinical results in a phase 3 trial, Pfizer and Valneva have filed their Lyme disease vaccine candidate PF-07307405 in the EU.

Japan first approval for GSK’s bepirovirsen for CHB

UK MHRA authorises orforglipron private prescription

J&J scores EU approval for Tecvayli combo in second line

Trump taps White House aide Heidi Overton to lead FDA

MHRA clarifies UK position on microbiome-based medicines

Pfizer, Valneva Lyme vaccine starts review in Europe

Lilly partners with Hims & Hers on obesity drug sales

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks